Susan Kenter

650 total citations
8 papers, 471 citations indexed

About

Susan Kenter is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Susan Kenter has authored 8 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Neurology and 2 papers in Genetics. Recurrent topics in Susan Kenter's work include Chromatin Remodeling and Cancer (5 papers), Neurofibromatosis and Schwannoma Cases (5 papers) and Cancer Mechanisms and Therapy (2 papers). Susan Kenter is often cited by papers focused on Chromatin Remodeling and Cancer (5 papers), Neurofibromatosis and Schwannoma Cases (5 papers) and Cancer Mechanisms and Therapy (2 papers). Susan Kenter collaborates with scholars based in Netherlands, Germany and United States. Susan Kenter's co-authors include Theo J.M. Hulsebos, Esther Middelkoop, Jan R. Mekkes, Miriam A.M. Loots, Jan D. Bos, Frank Baas, Jan M. Kooter, Maike Stam, Rik van Blokland and Renier A. L. van der Hoorn and has published in prestigious journals such as The Plant Journal, Human Molecular Genetics and The American Journal of Surgical Pathology.

In The Last Decade

Susan Kenter

8 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Kenter Netherlands 7 235 137 122 90 77 8 471
Peisheng Jin China 12 140 0.6× 91 0.7× 8 0.1× 11 0.1× 53 0.7× 29 431
Kate Wicks United Kingdom 10 333 1.4× 100 0.7× 41 0.3× 3 0.0× 33 0.4× 20 643
Shun Yu China 12 129 0.5× 144 1.1× 3 0.0× 46 0.5× 34 0.4× 30 418
Olga Kashpur United States 12 267 1.1× 186 1.4× 62 0.5× 10 0.1× 16 555
Manoj K. Valluru United Kingdom 9 324 1.4× 57 0.4× 118 1.0× 2 0.0× 12 0.2× 16 485
Chao-wu Tang China 12 182 0.8× 260 1.9× 5 0.0× 3 0.0× 52 0.7× 32 585
Ee-Kim Tan Singapore 7 147 0.6× 78 0.6× 9 0.1× 54 0.6× 6 0.1× 7 355
Zhensen Zhu China 8 93 0.4× 259 1.9× 6 0.0× 3 0.0× 34 0.4× 13 457
Mingfu Zhou United States 4 122 0.5× 59 0.4× 6 0.0× 3 0.0× 41 0.5× 5 538
Sabine Pfeifer Austria 10 150 0.6× 44 0.3× 7 0.1× 5 0.1× 19 0.2× 14 430

Countries citing papers authored by Susan Kenter

Since Specialization
Citations

This map shows the geographic impact of Susan Kenter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Kenter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Kenter more than expected).

Fields of papers citing papers by Susan Kenter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Kenter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Kenter. The network helps show where Susan Kenter may publish in the future.

Co-authorship network of co-authors of Susan Kenter

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Kenter. A scholar is included among the top collaborators of Susan Kenter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Kenter. Susan Kenter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Weterman, Marian A. J., Susan Kenter, Dyah W. Karjosukarso, et al.. (2018). Hypermorphic and hypomorphic AARS alleles in patients with CMT2N expand clinical and molecular heterogeneities. Human Molecular Genetics. 27(23). 4036–4050. 26 indexed citations
2.
Hulsebos, Theo J.M., Susan Kenter, Frank Baas, et al.. (2016). Type 1 papillary renal cell carcinoma in a patient with schwannomatosis: Mosaic versus loss of SMARCB1 expression in respectively schwannoma and renal tumor cells. Genes Chromosomes and Cancer. 55(4). 350–354. 8 indexed citations
3.
Hulsebos, Theo J.M., Susan Kenter, W. I. M. Verhagen, et al.. (2014). Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumors. Acta Neuropathologica. 128(3). 439–448. 21 indexed citations
4.
Hulsebos, Theo J.M., Susan Kenter, Ulrike Siebers‐Renelt, et al.. (2014). SMARCB1 Involvement in the Development of Leiomyoma in a Patient With Schwannomatosis. The American Journal of Surgical Pathology. 38(3). 421–425. 23 indexed citations
5.
Hulsebos, Theo J.M., Susan Kenter, Volkmar Hans, et al.. (2014). Expression of Mutant SMARCB1 Proteins in Schwannomas of Schwannomatosis Patients. Cancer Genetics. 207(9). 450–451. 1 indexed citations
6.
Munckhof, Pepijn van den, Imke Christiaans, Susan Kenter, Frank Baas, & Theo J.M. Hulsebos. (2011). Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri. Neurogenetics. 13(1). 1–7. 87 indexed citations
7.
Loots, Miriam A.M., et al.. (2002). Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. European Journal of Cell Biology. 81(3). 153–160. 168 indexed citations
8.
Stam, Maike, Susan Kenter, Renier A. L. van der Hoorn, et al.. (1997). Post‐transcriptional silencing of chalcone synthase in Petunia by inverted transgene repeats. The Plant Journal. 12(1). 63–82. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026